New hope for tough breast cancer: drug combo shrinks tumors before surgery
Disease control
Recruiting now
This study tests whether adding darolutamide, a drug that blocks male hormones, to standard chemotherapy and immunotherapy before surgery can shrink tumors more effectively in people with early-stage androgen receptor positive triple-negative breast cancer. About 51 participants …
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated May 01, 2026 15:57 UTC